Cargando…
Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritatio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443649/ https://www.ncbi.nlm.nih.gov/pubmed/32884545 http://dx.doi.org/10.1159/000508815 |
_version_ | 1783573667362373632 |
---|---|
author | Arnon, Roee Yahalomi, Tal Rozen-Knisbacher, Irit Pikkel, Joseph Mostovoy, Dina |
author_facet | Arnon, Roee Yahalomi, Tal Rozen-Knisbacher, Irit Pikkel, Joseph Mostovoy, Dina |
author_sort | Arnon, Roee |
collection | PubMed |
description | Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritation. Her examination showed crossed diplopia and alternating exotropia of 25 prism diopters, severe blepharitis, conjunctival hyperemia, corneal pannus, epithelial irregularities, and subepithelial opacities. Workup included pediatric neurologic examination, laboratory tests, imaging, and electrophysiological tests. Diagnoses of OMG and blepharitis with ocular surface disease were made. Topical treatment included eyelid hygiene, tea tree oil scrubbing, topical steroids, and tacrolimus ointment. Systemic treatment included corticosteroids, pyridostigmine, azathioprine, intravenous immunoglobulins, amitriptyline, and doxycycline. Both diseases were refractory to intensive immunosuppressive treatment and had simultaneous relapses and an intertwined course. Our hypothesis is that a shared immune mechanism may be the cause of both OMG and ocular surface disease in our patient. |
format | Online Article Text |
id | pubmed-7443649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-74436492020-09-02 Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report Arnon, Roee Yahalomi, Tal Rozen-Knisbacher, Irit Pikkel, Joseph Mostovoy, Dina Case Rep Ophthalmol Case Report Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritation. Her examination showed crossed diplopia and alternating exotropia of 25 prism diopters, severe blepharitis, conjunctival hyperemia, corneal pannus, epithelial irregularities, and subepithelial opacities. Workup included pediatric neurologic examination, laboratory tests, imaging, and electrophysiological tests. Diagnoses of OMG and blepharitis with ocular surface disease were made. Topical treatment included eyelid hygiene, tea tree oil scrubbing, topical steroids, and tacrolimus ointment. Systemic treatment included corticosteroids, pyridostigmine, azathioprine, intravenous immunoglobulins, amitriptyline, and doxycycline. Both diseases were refractory to intensive immunosuppressive treatment and had simultaneous relapses and an intertwined course. Our hypothesis is that a shared immune mechanism may be the cause of both OMG and ocular surface disease in our patient. S. Karger AG 2020-07-13 /pmc/articles/PMC7443649/ /pubmed/32884545 http://dx.doi.org/10.1159/000508815 Text en Copyright © 2020 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Arnon, Roee Yahalomi, Tal Rozen-Knisbacher, Irit Pikkel, Joseph Mostovoy, Dina Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report |
title | Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report |
title_full | Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report |
title_fullStr | Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report |
title_full_unstemmed | Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report |
title_short | Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report |
title_sort | ocular myasthenia gravis with severe blepharitis and ocular surface disease: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443649/ https://www.ncbi.nlm.nih.gov/pubmed/32884545 http://dx.doi.org/10.1159/000508815 |
work_keys_str_mv | AT arnonroee ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport AT yahalomital ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport AT rozenknisbacheririt ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport AT pikkeljoseph ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport AT mostovoydina ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport |